| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $267.27M | - | |
| Dir | 390.7K | $88.26M | - | |
| CEO | 152.2K | $34.38M | - | |
| VP | 72.6K | $16.41M | - | |
| CFO | 59.6K | $13.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2018 | Berns Paul L | Director | Sell | 660 | $176.61 | $116,563.19 | -8.9% | |
| Aug 10, 2018 | Riedel Norbert G63 | Director | Sell | 660 | $176.61 | $116,563.06 | -9.2% | |
| Aug 10, 2018 | Winningham Rick E64 | Director | Sale+OE | 16,639 | $176.18 | $2,931,400.75 | -35.1% | |
| Aug 10, 2018 | Gray Peter63 | Director | Sell | 715 | $176.61 | $126,276.58 | -8.0% | |
| Aug 10, 2018 | O'Keefe Kenneth W63 | Director | Sell | 660 | $176.61 | $116,563.00 | -12.9% | |
| Aug 10, 2018 | McSharry Heather Ann61 | Director | Sell | 715 | $176.61 | $126,276.44 | -8.7% | |
| Aug 10, 2018 | Schnee Elmar | Director | Sell | 742 | $176.61 | $131,044.92 | -10.9% | |
| Aug 10, 2018 | Sohn Catherine A.55 | Director | Sell | 660 | $176.61 | $116,563.13 | -7.9% | |
| Aug 10, 2018 | Enright Patrick G74 | Director | Sell | 1,365 | $175.13 | $239,057.09 | -7.7% | |
| Aug 1, 2018 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,600 | $173.90 | $278,240.00 | -0.6% |